Found 1 articles for: "cancer treatment continuation"

Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series
July 2026 | Volume 25 | Issue 7 | Case Reports | 659 | Copyright © July 2026
Background: Aromatase inhibitors (AIs) and anti-HER2 therapies improve breast cancer survival, but dermatologic adverse events (dAEs) are underrecognized despite affecting qualit...
Read More